Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Merck & Co., Inc. (MRK)
Market Closed
17 Jul, 20:00
NYSE
All
(16)
DE
(7)
AT
(1)
CL
(1)
MX
(1)
IT
(2)
GB
(3)
US
(1)
NYSE
Primary
LSE
XMIL
XHAN
XMUN
XETRA
XSTU
XDUS
XSTU
LSE
XMEX
XSGO
XWBO
XFRA
XMIL
CBOE
$
127.
50
-0.13
-0.1019%
$
298.35B
Market Cap
58.39
P/E Ratio
0.77%
Div Yield
13.47M
Volume
1.46
Eps
$
127.63
Previous Close
Investors:
TJD
DI
MSH
TMB
LC
+1168
Analysts:
EDS
TH
Watching
Watch
Add Transaction
Day Range
127.03
131.74
Year Range
76.66
131.74
Want to track
MRK
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Earnings
Splits
Statistics
News
Historical Data
Investors
Analysts
Merck & Co., Inc. (MRK) Statistics
Valuation metrics
Market Cap
298.35B
Enterprise value
358.69B
Trailing P/E (ttm)
35.81
Forward P/E
11.52
PEG ratio
-0.74
Price/Sales (ttm)
4.8
Price/Book (mrq)
6.87
Enterprise Value/Revenue
5.47
Enterprise Value/EBITDA
19.1
Overview
Shares outstanding
2.47B
Float
2.47B
Shares short
27.5M
% Held by insiders
0%
% Held by institutions
0.81%
Average volume (10 days)
8.9M
Average volume (90 days)
9.81M
Price summary
52-Week low
76.66
52-Week high
131.74
Beta
0.28
50-Day moving average
123.46
200-Day moving average
116.81
Dividends and splits
Forward annual dividend rate
3.4
Forward annual dividend yield
0.0303%
Trailing annual dividend rate
3.36
Trailing annual dividend yield
0.0264%
5-Year annual dividend yield
3.02%
Payout ratio
0.92
Dividend Date
8 Jul 2026
Ex-Dividend Date
15 Jun 2026
Last split factor
1,048:1,000
Last split Date
3 Jun 2021
Financials
Fiscal year
Fiscal year ends
31 Dec 2025
Most recent quarter (mrq)
31 Mar 2026
Profitability
Profit margin
0.14%
Operating margin
0.28%
Operational effectiveness
Return on assets
0.07%
Return on equity
0.18%
Income Statement
Revenue (ttm)
65.77B
Revenue per share (ttm)
26.53
Quarterly revenue growth (yoy)
0.05%
Gross profit (ttm)
50.38B
EBITDA
29.11B
Net income to common (ttm)
8.94B
Diluted EPS (ttm)
3.61
Quarterly earnings growth (yoy)
-0.21%
Balance Sheet
Total cash (mrq)
14.57B
Total cash per share (mrq)
2.31
Total debt (mrq)
50.53B
Total Debt/Equity (mrq)
1.07
Current ratio (mrq)
1.3%
Book value per share (mrq)
18.58
Cash Flow
Cash flow statement
18.49B
Levered free cash flow (LFCF)
18.25B